Literature DB >> 26424758

Familial Gastric Cancers.

Namrata Setia1, Jeffrey W Clark2, Dan G Duda3, Theodore S Hong3, Eunice L Kwak2, John T Mullen4, Gregory Y Lauwers5.   

Abstract

Although the majority of gastric carcinomas are sporadic, approximately 10% show familial aggregation, and a hereditary cause is determined in 1%-3% cases. Of these, hereditary diffuse gastric cancer is the most recognized predisposition syndrome. Although rare, the less commonly known syndromes also confer a markedly increased risk for development of gastric cancer. Identification and characterization of these syndromes require a multidisciplinary effort involving oncologists, surgeons, genetic counselors, biologists, and pathologists. This article reviews the molecular genetics, clinical and pathologic features, surveillance guidelines, and preventive measures of common and less common hereditary gastric cancer predisposition syndromes. ©AlphaMed Press.

Entities:  

Keywords:  Cancer; Familial; Hereditary; Stomach; Syndromic

Mesh:

Year:  2015        PMID: 26424758      PMCID: PMC4679084          DOI: 10.1634/theoncologist.2015-0205

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  130 in total

1.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  [18F]Fluorodeoxyglucose positron emission tomography/computed tomography-positive gastric adenocarcinoma in a 12-year-old girl with Peutz-Jeghers syndrome.

Authors:  Christina Schneider; Thorsten Simon; Barbara Hero; Ursula Schulze Uphoff; Uta Drebber; Hakan Alakus; Elke Holinski-Feder; Frank Berthold; Markus Dietlein; Matthias C Schmidt
Journal:  J Clin Oncol       Date:  2012-04-09       Impact factor: 44.544

3.  Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer.

Authors:  S Semba; H Yokozaki; W Yasui; E Tahara
Journal:  Int J Oncol       Date:  1998-06       Impact factor: 5.650

4.  Gastric adenocarcinoma in a patient with xeroderma pigmentosum.

Authors:  L Puig; R Martí; X Matías-Guiu; M Lecha; M Guix
Journal:  Br J Dermatol       Date:  1985-11       Impact factor: 9.302

Review 5.  Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.

Authors:  Parry Guilford; Bostjan Humar; Vanessa Blair
Journal:  Gastric Cancer       Date:  2010-04-07       Impact factor: 7.370

6.  Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis.

Authors:  T T Wu; S Kornacki; A Rashid; J H Yardley; S R Hamilton
Journal:  Am J Surg Pathol       Date:  1998-03       Impact factor: 6.394

7.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

8.  Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.

Authors:  J Lorenzo Bermejo; K Hemminki
Journal:  Ann Oncol       Date:  2004-12       Impact factor: 32.976

9.  The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment.

Authors:  T Iwama; Y Mishima; J Utsunomiya
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

10.  Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

Authors:  Johanne Geary; Peter Sasieni; Richard Houlston; Louise Izatt; Ros Eeles; Stewart J Payne; Samantha Fisher; Shirley V Hodgson
Journal:  Fam Cancer       Date:  2007-10-16       Impact factor: 2.375

View more
  10 in total

Review 1.  Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.

Authors:  Evangelos Koustas; Eleni-Myrto Trifylli; Panagiotis Sarantis; Nikolaos Papadopoulos; Eleni Karapedi; Georgios Aloizos; Christos Damaskos; Nikolaos Garmpis; Anna Garmpi; Kostas A Papavassiliou; Michalis V Karamouzis; Athanasios G Papavassiliou
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

2.  Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.

Authors:  M Aronson; C Swallow; A Govindarajan; K Semotiuk; Z Cohen; P Kaurah; L Velsher; I Ambus; K Buckley; C Forster-Gibson; W S Meschino; A Blumenthal; R H Kim; S Brar
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

3.  KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition.

Authors:  Soo-Jeong Cho; Changhwan Yoon; Jun Ho Lee; Kevin K Chang; Jian-Xian Lin; Young-Ho Kim; Myeong-Cherl Kook; Bülent Arman Aksoy; Do Joong Park; Hassan Ashktorab; Duane T Smoot; Nikolaus Schultz; Sam S Yoon
Journal:  Clin Cancer Res       Date:  2018-08-14       Impact factor: 12.531

4.  Clinicopathological Features and Survival of Patients with Gastric Cancer with a Family History: a Large Analysis of 2,736 Patients with Gastric Cancer.

Authors:  Oh Jeong; Mi Ran Jung; Young Kyu Park; Seong Yeob Ryu
Journal:  J Gastric Cancer       Date:  2017-06-20       Impact factor: 3.720

Review 5.  Hereditary gastric cancer: Three rules to reduce missed diagnoses.

Authors:  Paula Assumpção; Taíssa Araújo; André Khayat; Geraldo Ishak; Sidney Santos; Williams Barra; João Felipe Acioli; Benedito Rossi; Paulo Assumpção
Journal:  World J Gastroenterol       Date:  2020-04-07       Impact factor: 5.742

Review 6.  Environmental and genetic risk factors for gastric cancer.

Authors:  Dhavan Shah; David Bentrem
Journal:  J Surg Oncol       Date:  2022-06       Impact factor: 2.885

7.  A Rare MSH2 Variant as a Candidate Marker for Lynch Syndrome II Screening in Tunisia: A Case of Diffuse Gastric Carcinoma.

Authors:  Maria Kabbage; Jihenne Ben Aissa-Haj; Houcemeddine Othman; Amira Jaballah-Gabteni; Sarra Laarayedh; Sahar Elouej; Mouna Medhioub; Haifa Tounsi Kettiti; Amal Khsiba; Moufida Mahmoudi; Houda BelFekih; Afifa Maaloul; Hassen Touinsi; Lamine Hamzaoui; Emna Chelbi; Sonia Abdelhak; Mohamed Samir Boubaker; Mohamed Mousaddak Azzouz
Journal:  Genes (Basel)       Date:  2022-07-28       Impact factor: 4.141

8.  Family history of malignant tumor is a predictor of gastric cancer prognosis: Incorporation into a nomogram.

Authors:  Fanke Wang; Liqiao Fan; Qun Zhao; Yu Liu; Zhidong Zhang; Dong Wang; Xuefeng Zhao; Yong Li; Bibo Tan
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

9.  Sex-specific familial aggregation of cancers in Finland.

Authors:  Lauri J Sipilä; Karri Seppä; Mervi Aavikko; Janne Ravantti; Sanna Heikkinen; Lauri A Aaltonen; Janne Pitkäniemi
Journal:  Sci Rep       Date:  2022-09-06       Impact factor: 4.996

Review 10.  Helicobacter pylori Oncogenicity: Mechanism, Prevention, and Risk Factors.

Authors: 
Journal:  ScientificWorldJournal       Date:  2020-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.